STATINE

STATINE Structure
CAS No.
49642-07-1
Chemical Name:
STATINE
Synonyms
STATIN;STATINE;H-STA-OH;S)-Statine;LEU-STATINE;4S)-Statine;(S,S)-Statine;H-STA(3S,4S)-OH;(3S,4S)-STATINE;H-(3S,4S)-STA-OH
CBNumber:
CB9272763
Molecular Formula:
C8H17NO3
Molecular Weight:
175.23
MOL File:
49642-07-1.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:41

STATINE Properties

Melting point 209 °C
alpha D15 -20° (c = 0.64 in water)
Boiling point 306.53°C (rough estimate)
Density 1.1233 (rough estimate)
refractive index 1.4476 (estimate)
storage temp. 2-8°C
solubility 0.5 M HCl: 50 mg/mL, clear, very faintly yellow
pka 3.97±0.10(Predicted)
form Solid
color White to off-white
Merck 13,8879

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H319-H315-H335
Precautionary statements  P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36
WGK Germany  3

STATINE Chemical Properties,Uses,Production

Chemical Properties

white powder

Clinical Use

With the possible exception of atorvastatin, the statins are used to lower LDL cholesterol in familial or polygenic ( multifactorial) hypercholesterolemia (type IIa) and in combination with triglyceride-lowering drugs to treat combined hyperlipidemia (type IIb) when both LDL and VLDL (very low density lipoproteins) are elevated. However, the statins probably should not be given with the fibrates (triglyceridelowering drugs, discussed later), since this combination may greatly increase statin toxicity. Atorvastatin, the most potent of the available statins, has also been shown to lower blood triglycerides significantly.
This effect may be due to decreasing hepatic cholesterol and cholesterol ester levels to such an extent that hepatic formation of VLDL is impaired.The statins also have been claimed to reduce blood cholesterol levels modestly in some patients with homozygous familial hypercholesterolemia, a condition often fatal in childhood or in early adulthood.
The statins may lower the risk of CHD by decreasing inflammation, an important component of atherogenesis. Lovastatin decreased elevated plasma levels of Creactive protein, a marker for cellular inflammation, and acute coronary events in patients with relatively low plasma cholesterol levels. Recent studies also suggest that use of statins may decrease the risk of stroke, dementia, and Alzheimer’s disease and may improve bone density in postmenopausal women. These broad actions may be related to the hypocholesterolemic, antiproliferative, antiinflammatory, or antioxidant properties of the statins or some combination of these properties.

Side effects

The statins generally appear to be well tolerated, with muscle pain and liver dysfunction seen in 1 to 2% of patients. However, the consequences of 20 to 30 years of continuous use are unknown. This fact has been dramatically reinforced by the recent recognition of a potentially fatal consequence of statin use. A relatively common side effect of the statins (perhaps 1% of patients) is myositis, that is, inflammation of skeletal muscle accompanied by pain, weakness, and high levels of serum creatine kinase. Rhabdomyolysis, i.e., disintegration of muscle with urinary excretion of myoglobin and kidney damage, was considered to be a rare and extreme toxic outcome. However, cerivastatin (Baycol) has now been withdrawn from the market by its manufacturer (Bayer) because of 31 deaths linked to fatal rhabdomyolysis. The risk of muscle damage is said to increase with simultaneous use of the triglyceride-lowering fibrates. Pravastatin may be less toxic than other statins because it does not readily penetrate extrahepatic cells and may be more confined to the liver after oral dosage.

STATINE Suppliers

Global( 65)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 +1-00000000000 United States 19892 58 Inquiry
Career Henan Chemica Co +86-0371-86658258 +8613203830695 China 30253 58 Inquiry
BOC Sciences 16314854226; +16314854226 United States 19743 58 Inquiry
Nextpeptide Inc +86-0571-81612335 +8613336028439 China 19915 58 Inquiry
LEAPCHEM CO., LTD. +86-852-30606658 China 43348 58 Inquiry
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919 China 6526 58 Inquiry
Hangzhou Sinoda Pharmaceutical Technology Co. LTD 0571-87213919 17306812703 China 6213 58 Inquiry
Beijing Ouhe Technology Co., Ltd 010-82967028 13552068683 China 12439 60 Inquiry
Combi-Blocks Inc. 858 635 8950 United States 6632 69 Inquiry
MedChemExpress 021-58955995 United States 6398 58 Inquiry
STATIN STATINE H-STA(3S,4S)-OH H-STA-OH H-(3S,4S)-STA-OH LEU-STATINE (3S,4S)-4-AMINO-3-HYDRO-6-METHYLHEPTANOIC ACID (3S,4S)-(-)-STATINE (3S,4S)-STATINE (3S,4S)-4-AMINO-3-HYDROXY-6-METHYLHEPTANOIC ACID (3S,4S)-4-AMINO-3-HYDROXY-L-METHYLHEPTANOIC ACID Sta(3S,4S)-OH·HCl Statine Hydrochloride≥ 98% (TLC) (3S,4S)-(-)-Statine,98% (3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid hydrochloride Statine *CAS 49642-07-1* (S,S)-Statine Heptanoic acid, 4-amino-3-hydroxy-6-methyl-, (3S,4S)- 4S)-Statine S)-Statine 49642-07-1 Unnatural Amino Acid Derivatives Peptide Synthesis Others Specialty Synthesis Amino Acids